First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.

Claus-Henning Köhne; Ralf Hofheinz; Laurent Mineur; Henry Letocha; Richard Greil; Josef Thaler; Eva Fernebro; Erick Gamelin; Lucy Decosta; Meinolf Karthaus

doi:10.1007/s00432-011-1061-6

First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.

Claus-Henning Köhne, Ralf Hofheinz, Laurent Mineur, Henry Letocha, Richard Greil (Co-author), Josef Thaler, Eva Fernebro, Erick Gamelin, Lucy Decosta, Meinolf Karthaus

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

63 Citations (Web of Science)

Original language	English
Pages (from-to)	65-72
Journal	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume	138
Issue number	1
DOIs	https://doi.org/10.1007/s00432-011-1061-6
Publication status	Published - 2012

Keywords

GROWTH-FACTOR RECEPTOR
PHASE-III TRIAL
INITIAL TREATMENT
CETUXIMAB
IRINOTECAN
FLUOROURACIL
KRAS
LEUCOVORIN
CHEMOTHERAPY
OXALIPLATIN

Access to Document

10.1007/s00432-011-1061-6

Cite this

Köhne, C.-H., Hofheinz, R., Mineur, L., Letocha, H., Greil, R., Thaler, J., Fernebro, E., Gamelin, E., Decosta, L., & Karthaus, M. (2012). First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , 138(1), 65-72. https://doi.org/10.1007/s00432-011-1061-6

Köhne, Claus-Henning ; Hofheinz, Ralf ; Mineur, Laurent et al. / First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer. In: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2012 ; Vol. 138, No. 1. pp. 65-72.

@article{4e533a4685fb4d4c92d192a859820658,

title = "First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.",

keywords = "GROWTH-FACTOR RECEPTOR, PHASE-III TRIAL, INITIAL TREATMENT, CETUXIMAB, IRINOTECAN, FLUOROURACIL, KRAS, LEUCOVORIN, CHEMOTHERAPY, OXALIPLATIN",

author = "Claus-Henning K{\"o}hne and Ralf Hofheinz and Laurent Mineur and Henry Letocha and Richard Greil and Josef Thaler and Eva Fernebro and Erick Gamelin and Lucy Decosta and Meinolf Karthaus",

note = "R. Greil Third Medical Department, University Hospital Salzburg, Salzburg, Austria",

year = "2012",

doi = "10.1007/s00432-011-1061-6",

language = "English",

volume = "138",

pages = "65--72",

journal = "JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY ",

issn = "0171-5216",

publisher = "Springer Nature",

number = "1",

}

Köhne, C-H, Hofheinz, R, Mineur, L, Letocha, H, Greil, R, Thaler, J, Fernebro, E, Gamelin, E, Decosta, L & Karthaus, M 2012, 'First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.', JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol. 138, no. 1, pp. 65-72. https://doi.org/10.1007/s00432-011-1061-6

First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer. / Köhne, Claus-Henning; Hofheinz, Ralf; Mineur, Laurent et al.
In: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , Vol. 138, No. 1, 2012, p. 65-72.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.

AU - Köhne, Claus-Henning

AU - Hofheinz, Ralf

AU - Mineur, Laurent

AU - Letocha, Henry

AU - Greil, Richard

AU - Thaler, Josef

AU - Fernebro, Eva

AU - Gamelin, Erick

AU - Decosta, Lucy

AU - Karthaus, Meinolf

N1 - R. Greil Third Medical Department, University Hospital Salzburg, Salzburg, Austria

PY - 2012

Y1 - 2012

KW - GROWTH-FACTOR RECEPTOR

KW - PHASE-III TRIAL

KW - INITIAL TREATMENT

KW - CETUXIMAB

KW - IRINOTECAN

KW - FLUOROURACIL

KW - KRAS

KW - LEUCOVORIN

KW - CHEMOTHERAPY

KW - OXALIPLATIN

U2 - 10.1007/s00432-011-1061-6

DO - 10.1007/s00432-011-1061-6

M3 - Original Article

C2 - 21960318

SN - 0171-5216

VL - 138

SP - 65

EP - 72

JO - JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

JF - JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

IS - 1

ER -

Köhne CH, Hofheinz R, Mineur L, Letocha H, Greil R, Thaler J et al. First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY . 2012;138(1):65-72. doi: 10.1007/s00432-011-1061-6